s6y

LIFECORE BIOMEDICAL, INC. \DE\

Ticker
LFCR
CIK
1005286
Industry
Pharmaceutical Preparations
Formerly
LANDEC CORP \CA\

Financials 139

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-KT Transition report pursuant to Rule 13a-10 or 15d-10 for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-K Annual Report for period ending May 25, 2025
  7. 10-Q Quarterly Report for period ending Feb 23, 2025
  8. 10-Q Quarterly Report for period ending Nov 24, 2024
  9. 10-Q Quarterly Report for period ending Aug 25, 2024
  10. 10-K Annual Report for period ending May 26, 2024

All 139 financials filings

News 292

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 292 news filings

Ownership 1,146

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 1,146 ownership filings

Prospectus 41

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-3 Registration statement for specified transactions by certain issuers
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. S-1 General form of registration statement for all companies including face-amount certificate companies
  6. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. S-1/A General form of registration statement for all companies including face-amount certificate companies
  10. S-1 General form of registration statement for all companies including face-amount certificate companies

All 41 prospectus filings

Proxies 46

  1. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. PREM14A Preliminary proxy statement relating to a merger, acquisition, or disposition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements

All 46 proxies filings

Other 82

  1. SCHEDULE 13G/A
  2. SCHEDULE 13D/A
  3. SCHEDULE 13D/A
  4. SCHEDULE 13G
  5. SCHEDULE 13D/A
  6. SCHEDULE 13D/A
  7. SCHEDULE 13G/A
  8. SCHEDULE 13G
  9. SCHEDULE 13G/A
  10. EFFECT Notice of Effectiveness

All 82 other filings